PH-responsive delivery of doxorubicin from citrate-apatite nanocrystals with tailored carbonate content

Langmuir

Volumn 29, Issue 26, 2013, Pages 8213-8221

  Rodríguez Ruiz, Isaac ^a   Delgado López, José Manuel ^a   Durán Olivencia, Miguel A ^a   Iafisco, Michele ^b   Tampieri, Anna ^b   Colangelo, Donato ^c   Prat, Maria ^c   Gómez Morales, Jaime ^a  

^a LABORATORIO DE ESTUDIOS CRISTALOGRÁFICOS   (Spain)

^b INSTITUTE OF SCIENCE AND TECHNOLOGY FOR CERAMICS   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC ACTIVITIES; DRUG-LOADING EFFICIENCY; HUMAN CARCINOMA CELLS; INTRACELLULAR COMPARTMENTS; INTRAVENOUS INJECTIONS; NANOCRYSTALLINE APATITES; NEGATIVELY CHARGED SURFACES; POTENTIAL MEASUREMENTS;

ADSORPTION ISOTHERMS; CARDIOVASCULAR SYSTEM; NANOPARTICLES; PH; SURFACE CHEMISTRY; SYNTHESIS (CHEMICAL);

APATITE;

ANTINEOPLASTIC ANTIBIOTIC; APATITE; CARBONIC ACID DERIVATIVE; CITRATE CALCIUM; DOXORUBICIN; DRUG CARRIER; NANOPARTICLE;

ARTICLE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; DRUG FORMULATION; HUMAN; KINETICS; PH; STATIC ELECTRICITY; THERMODYNAMICS; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTIBIOTICS, ANTINEOPLASTIC; APATITES; CALCIUM CITRATE; CARBONATES; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; STATIC ELECTRICITY; THERMODYNAMICS;

EID: 84880222183     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la4008334     Document Type: Article

References (59)

1. Grossman, J. H.; McNeil, S. E. Nanotechnology in cancer medicine Phys. Today 2012, 65, 38-42
2. Heath, J. R.; Davis, M. E. Nanotechnology and cancer Annu. Rev. Med. 2008, 59, 251-265
3. Ferrari, M. Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 2005, 5, 161-171
4. Pietronave, S.; Iafisco, M.; Locarno, D.; Rimondini, L.; Prat, M. Functionalized nanomaterials for diagnosis and therapy of cancer J. Appl. Biomater. Biomech. 2009, 7, 77-89
5. Schroeder, A.; Heller, D. A.; Winslow, M. M.; Dahlman, J. E.; Pratt, G. W.; Langer, R.; Jacks, T.; Anderson, D. G. Treating metastatic cancer with nanotechnology Nat. Rev. Cancer 2012, 12, 39-50
6. Manzoor, A. A.; Lindner, L. H.; Landon, C. D.; Park, J. Y.; Simnick, A. J.; Dreher, M. R.; Das, S.; Hanna, G.; Park, W.; Chilkoti, A.; Koning, G. A.; Ten Hagen, T. L. M.; Needham, D.; Dewhirst, M. W. Overcoming limitations in nanoparticle drug delivery: Triggered, intravascular release to improve drug penetration into tumors Cancer Res. 2012, 72, 5566-5575
7. Albanese, A.; Tang, P. S.; Chan, W. C. The effect of nanoparticle size, shape, and surface chemistry on biological systems Annu. Rev. Biomed. Eng. 2012, 14, 1-16
8. Gratton, S. E. A.; Ropp, P. A.; Pohlhaus, P. D.; Luft, J. C.; Madden, V. J.; Napier, M. E.; DeSimone, J. M. The effect of particle design on cellular internalization pathways Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 11613-11618
9. Qiu, Y.; Liu, Y.; Wang, L.; Xu, L.; Bai, R.; Ji, Y.; Wu, X.; Zhao, Y.; Li, Y.; Chen, C. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods Biomaterials 2010, 31, 7606-19
10. Doshi, N.; Mitragotri, S. Needle-shaped polymeric particles induce transient disruption of cell membranes J. R. Soc. Interface 2010, 6, 26
11. Koo, O. M.; Rubinstein, I.; Onyuksel, H. Role of nanotechnology in targeted drug delivery and imaging: a concise review Nanomed. Nanotechnol. Biol. Med. 2005, 1, 193-212
12. Forrest, M. L.; Kwon, G. S. Clinical developments in drug delivery nanotechnology Adv. Drug Delivery Rev. 2008, 60, 861-862
13. Amiji, M. M. Nanotechnology for targeted drug and gene delivery Nanomed.-Nanotechnol. 2006, 2, 299-300
14. Doane, T. L.; Burda, C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy Chem. Soc. Rev. 2012, 41, 2885-2911
15. Gómez-Morales, J.; Iafisco, M.; Delgado-López, J. M.; Sarda, S.; Drouet, C. Progress on the preparation of nanocrystalline apatites and surface characterization: Overview of fundamental and applied aspects Prog. Cryst. Growth Charact. 2013, 59, 1-46
16. Iafisco, M.; Palazzo, B.; Martra, G.; Margiotta, N.; Piccinonna, S.; Natile, G.; Gandin, V.; Marzano, C.; Roveri, N. Nanocrystalline carbonate-apatites: role of Ca/P ratio on the upload and release of anticancer platinum bisphosphonates Nanoscale 2012, 4, 206-17
17. Al-Kattan, A.; Girod-Fullana, S.; Charvillat, C.; Ternet-Fontebasso, H.; Dufour, P.; Dexpert-Ghys, J.; Santran, V.; Bordere, J.; Pipy, B.; Bernad, J.; Drouet, C. Biomimetic nanocrystalline apatites: Emerging perspectives in cancer diagnosis and treatment Int. J. Pharm. 2012, 423, 26-36
18. Zheng, C.; Xu, J.; Yao, X.; Xu, J.; Qiu, L. Polyphosphazene nanoparticles for cytoplasmic release of doxorubicin with improved cytotoxicity against Dox-resistant tumor cells J. Colloid Interface Sci. 2011, 355, 374-382
19. Xie, B.; Nancollas, G. H. How to control the size and morphology of apatite nanocrystals in bone Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 22369-22370
20. Hu, Y. Y.; Rawal, A.; Schmidt-Rohr, K. Strongly bound citrate stabilizes the apatite nanocrystals in bone Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 22425-22429
21. Delgado-López, J. M.; Iafisco, M.; Rodríguez, I.; Tampieri, A.; Prat, M.; Gómez-Morales, J. Crystallization of bioinspired citrate-functionalized nanoapatite with tailored carbonate content Acta Biomater. 2012, 8, 3491-3499
22. Wood, J. Doxorubicin. In The Cytotoxics Handbook, 4 th ed.; Allwood, A. S.; Wright, P., Eds.; Radcliffe Medical Press Ltd: Oxon, UK, 2002; p 8.
23. Beretta, G.; Zunino, F. Molecular Mechanisms of Anthracycline Activity. In Anthracycline Chemistry and Biology II; Krohn, K., Ed.; Springer: Berlin/Heidelberg, 2008; Vol. 283, pp 1-19.
24. Pindur, U.; Haber, M.; Sattler, K. Antitumor active drugs as intercalators of deoxyribonucleic acid: Molecular models of intercalation complexes J. Chem. Educ. 1993, 70, 263
25. Pigram, W. J.; Fuller, W.; Hamilton, L. D. Stereochemistry of intercalation: interaction of daunomycin with DNA Nat. New Biol. 1972, 235, 17-19
26. Aubel-Sadron, G.; Londos-Gagliardi, D. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review Biochimie 1984, 66, 333-352
27. Liao, L. B.; Zhou, H. Y.; Xiao, X. M. Spectroscopic and viscosity study of doxorubicin interaction with DNA J. Mol. Struct. 2005, 749, 108-113
28. Kremer, L. C. M.; van Dalen, E. C.; Offringa, M.; Vouîte, P. A. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review Ann. Oncol. 2002, 13, 503-512
29. Longhi, A.; Ferrari, S.; Bacci, G.; Specchia, S. Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma Anticancer Drugs 2007, 18, 737-744
30. Elliott, P. Pathogenesis of cardiotoxicity induced by anthracyclines Semin. Oncol. 2006, 33, S2-S7
31. Beijnen, J. H.; van der Houwen, O. A. G. J.; Underberg, W. J. M. Aspects of the degradation kinetics of doxorubicin in aqueous solution Int. J. Pharm. 1986, 32, 123-131
32. Langmuir, I. The adsorption of gases on plane surfaces of glass, mica and platinum J. Am. Chem. Soc. 1918, 40, 1361-1403
33. El Shafei, G. M. S.; Moussa, N. A. Adsorption of some essential amino acids on hydroxyapatite J. Colloid Interface Sci. 2001, 238, 160-166
34. Luo, Q.; Andrade, J. D. Cooperative adsorption of proteins onto hydroxyapatite J. Colloid Interface Sci. 1998, 200, 104-113
35. Rill, C.; Kolar, Z. I.; Kickelbick, G.; Wolterbeek, H. T.; Peters, J. A. Kinetics and thermodynamics of adsorption on hydroxyapatite of the [160Tb]terbium complexes of the bone-targeting ligands DOTP and BPPED Langmuir 2009, 25, 2294-2301
36. Giordano, S.; Ponzetto, C.; Renzo, M. F. D.; Cooper, C. S.; Comoglio, P. M. Tyrosine kinase receptor indistinguishable from the c-met protein Nature 1989, 339, 155-156
37. López-Macipe, A.; Gómez-Morales, J.; Rodríguez- Clemente, R. Nanosized hydroxyapatite precipitation from homogeneous calcium/citrate/phosphate solutions using microwave and conventional heating Adv. Mater. 1998, 10, 49-53
38. Misra, D. N.; Bowen, R. L.; Mattamal, G. J. Surface area of dental enamel, bone, and hydroxyapatite: Chemisorption from solution Calcif. Tissue Int. 1978, 26, 139-142
39. Lowenstam, H. A.; Weiner, S. On Biomineralization; University Press: Oxford, 1989.
40. Mann, S. Biomineralization: principles and concepts in bioinorganic materials chemistry; University Press: Oxford, 2001.
41. Sharma, S.; Agarwal, G. P. Interactions of proteins with immobilized metal ions: role of ionic strength and pH J. Colloid Interface Sci. 2001, 243, 61-72
42. Sips, R. On the Structure of a Catalyst Surface J. Chem. Phys. 1948, 16, 490-495
43. Ramírez-Rodríguez, G. B.; Delgado-López, J. M.; Gómez-Morales, J. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situ Raman microspectroscopy CrystEngComm 2013, 15, 2206-2212
44. Beljebbar, A.; Sockalingum, G. D.; Angiboust, J. F.; Manfait, M. Comparative FT SERS, resonance Raman and SERRS studies of doxorubicin and its complex with DNA Spectrochim. Acta Part A: Mol. Biomol. Spectrosc. 1995, 51, 2083-2090
45. Barick, K. C.; Nigam, S.; Bahadur, D. Nanoscale assembly of mesoporous ZnO: A potential drug carrier J. Mater. Chem. 2010, 20, 6446-6452
46. Das, G.; Nicastri, A.; Coluccio, M. L.; Gentile, F.; Candeloro, P.; Cojoc, G.; Liberale, C.; De Angelis, F.; Di Fabrizio, E. FT-IR, Raman, RRS measurements and DFT calculation for doxorubicin Microsc. Res. Tech. 2010, 73, 991-995
47. Sturgeon, R. J.; Schulman, S. G., Electronic absorption spectra and protolytic equilibria of doxorubicin: Direct spectrophotometric determination of microconstants J. Pharm. Sci. 1977, 66, 958-961
48. Land, E. J.; Mukherjee, T.; Swallow, A. J.; Bruce, J. M. One-electron reduction of adriamycin: Properties of the semiquinone Arch. Biochem. Biophys. 1983, 225, 116-121
49. Agrawal, P.; Barthwal, S. K.; Barthwal, R. Studies on self-aggregation of anthracycline drugs by restrained molecular dynamics approach using nuclear magnetic resonance spectroscopy supported by absorption, fluorescence, diffusion ordered spectroscopy and mass spectrometry Eur. J. Med. Chem. 2009, 44, 1437-51
50. Rajendran, L.; Knolker, H.-J.; Simons, K. Subcellular targeting strategies for drug design and delivery Nat. Rev. Drug Discovery 2010, 9, 29-42
51. Sahay, G.; Alakhova, D. Y.; Kabanov, A. V. Endocytosis of nanomedicines J. Controlled Release 2010, 145, 182-195
52. Minotti, G.; Menna, P.; Salvatorelli, E.; Cairo, G.; Gianni, L. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity Pharmacol. Rev. 2004, 56, 185-229
53. Ambudkar, S. V.; Kimchi-Sarfaty, C.; Sauna, Z. E.; Gottesman, M. M. P-glycoprotein: from genomics to mechanism Oncogene 2003, 22, 7468-7485
54. Chang, J.-E.; Shim, W.-S.; Yang, S.-G.; Kwak, E.-Y.; Chong, S.; Kim, D.-D.; Chung, S.-J.; Shim, C.-K. Liver cancer targeting of doxorubicin with reduced distribution to the heart using hematoporphyrin-modified albumin nanoparticles in rats Pharm. Res. 2012, 29, 795-805
55. Padhye, S. S.; Guin, S.; Yao, H. P.; Zhou, Y. Q.; Zhang, R.; Wang, M. H. Sustained expression of the RON receptor tyrosine kinase by pancreatic cancer stem cells as a potential targeting moiety for antibody-directed chemotherapeutics Mol. Pharm. 2011, 8, 2310-9
56. Shi, M.; Ho, K.; Keating, A.; Shoichet, M. S. Doxorubicin-conjugated immuno-nanoparticles for intracellular anticancer drug delivery Adv. Funct. Mater. 2009, 19, 1689-1696
57. Iafisco, M.; Delgado-López, J. M.; Varoni, E. M.; Tampieri, A.; Rimondini, L.; Gómez-Morales, J.; Prat, M. Cell surface receptor targeted biomimetic apatite nanocrystals for cancer therapy Small 2013, 10.1002/smll.201202843
58. Legeros, R. Z.; Trautz, O. R.; Legeros, J. P.; Klein, E.; Shirra, W. P. Apatite crystallites: effects of carbonate on morphology Science 1967, 155, 1409-1411
59. Rey, C.; Combes, C.; Drouet, C.; Sfihi, H.; Barroug, A. Physico-chemical properties of nanocrystalline apatites: Implications for biominerals and biomaterials Mater. Sci. Eng., C 2007, 27, 198-205